Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00935909 · ClinicalTrials.gov registry record
Use of Vein Viewer for Insertion of Peripheral Venous Cannula in Pediatric Patients With Difficult Intravenous Access
A clinical trial of IV Cannulation, sponsored by Peter Szmuk.
- Completed
- Registry status
- 603
- Enrollment target
- 1
- Study location
NCT00935909: Completed study of IV Cannulation, sponsored by Peter Szmuk.
NCT00935909 is a study of IV Cannulation that has completed, run by Peter Szmuk. The registered enrollment target is 603 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00935909, a study of IV Cannulation, has completed, sponsored by Peter Szmuk.
- COMPLETED
- Registry status
- 603 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this prospective, randomized trial is successful intravenous (IV) cannulation on first attempt with the use of either the Vein Viewer (VV) or standard cannulation method. The secondary purpose is to find out if there is a difference in the total time to successful cannulation.
Conditions Studied
Study Locations (1)
Texas
- Children's Medical Center Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 603 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-07 |
What the finished NCT00935909 record still lists
NCT00935909 is an observational study that tracks outcomes without assigning an intervention. The registered 603 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with IV Cannulation appearing as the primary indexed condition, and to 0 interventions.
NCT00935909 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00935909 about?
NCT00935909 is a clinical study titled "Use of Vein Viewer for Insertion of Peripheral Venous Cannula in Pediatric Patients With Difficult Intravenous Access". The primary purpose of this prospective, randomized trial is successful intravenous (IV) cannulation on first attempt with the use of either the Vein Viewer (VV) or standard cannulation method. The secondary purpose is to find out if there is a difference in the total time to successful cannulation.
What is the current status of trial NCT00935909?
This trial is currently completed. The enrollment target is 603 participants. The study started on 2009-01. Estimated completion is 2010-07.
What conditions does trial NCT00935909 study?
This clinical trial studies the following conditions: IV Cannulation.
Who is sponsoring clinical trial NCT00935909?
This trial is sponsored by Peter Szmuk, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00935909 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia